Walking meditation trial aims to strengthen resilience in neurodegenerative disease patients

NCT ID NCT07285954

Recruiting now Symptom relief Sponsor: University of Illinois at Urbana-Champaign Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a walking meditation program called iWalk for adults with neurodegenerative diseases like multiple sclerosis. The goal is to see if it's feasible and helps improve resilience, stress regulation, and thinking skills. Researchers will enroll 90 participants and measure outcomes like resilience scales and cognitive tests.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: walking meditation program (iWalk)
What this could lead to: If it works, this could offer a simple, drug-free way to help people with neurodegenerative diseases feel more resilient and manage stress better.
What could go wrong: This is a small, early feasibility study with only 90 participants, so results may not apply widely. The intervention is behavioral, so benefits may be modest or hard to measure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADULTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Emotional Regulation multiple sclerosis neurodegenerative disease Parkinson disease stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADULTS EEG MINDFULNESS NEURODEGENERATIVE DISEASE

Contacts and locations

Locations

University of Illinois Urbana-Champaign
RECRUITING

Urbana, Illinois, 61801, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.